Director, US Value, Access, and Pricing Strategy
Orca Bio- Full Time
- Senior (5 to 8 years)
Employment Type: Full time
At Illumina, we are advancing the future of cancer care by unlocking the power of the genome. As the Director of Global Market Access Strategy – Oncology, you will lead global strategies to ensure patients worldwide have access to our transformative oncology testing solutions. Spanning hereditary risk testing, solid and liquid tumor profiling and monitoring, your work will help shape the future of precision oncology. This includes Market Access strategies for emerging oncology testing applications and indications (e.g., WGS, MRD, and early detection).
This is a high-impact, strategic leadership role that requires deep expertise in oncology diagnostics, payer engagement, and global reimbursement landscapes. You will collaborate across regions and functions to shape the value narrative, secure reimbursement, and drive adoption of our technologies in diverse healthcare systems.
What if the work you did every day could impact the lives of people you know? Or all of humanity? At Illumina, we are expanding access to genomic technology to realize health equity for billions of people around the world. Our efforts enable life-changing discoveries that are transforming human health through the early detection and diagnosis of diseases and new treatment options for patients. Working at Illumina means being being part of something bigger than yourself. Every person, in every role, has the opportunity to make a difference. Surrounded by extraordinary people, inspiring leaders, and world changing projects, you will do more and become more than you ever thought possible.
Supports genomics startups through funding and resources
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.